165
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Respiratory Symptoms, Disease Burden, and Quality of Life in Australian Adults According to GOLD Spirometry Grades: Data from the BOLD Australia Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2839-2847 | Received 13 Jul 2023, Accepted 30 Oct 2023, Published online: 30 Nov 2023

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: 2023 report. global initiative for chronic obstructive lung disease; [ updated December 05, 2022]. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed December 01, 2022.
  • Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788.
  • World Health Organization (WHO). Chronic obstructive pulmonary disease (COPD). WHO; 2023 [ updated March 16 2023]. Available form: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed May 12, 2023.
  • Australian Institute of Health Welfare. Chronic obstructive pulmonary disease (COPD), associated comorbidities and risk factors. AIHW. Available form: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/copd-associated-comorbidities-risk-factors. Accessed April 21, 2023.
  • Australian Institute of Health Welfare. Australian burden of disease study 2015: interactive data on disease burden. AIHW. [ updated 2020]. Available from: https://www.aihw.gov.au/reports/burden-of-disease/abds-2015-interactive-data-disease-burden. Accessed April 15, 2023.
  • Sarkar M, Bhardwaj R, Madabhavi I, Khatana J. Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med. 2015;9:S22803.
  • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.00012408
  • Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Review. 2014;23(133):345–349. doi:10.1183/09059180.00007813
  • Australian Bureau of Statistics (ABS). National health survey: first results. ABS. [ Updated 2017-2018]. Available from: https://www.abs.gov.au/statistics/health/health-conditions-and-risks/national-health-survey-first-results/latest-release. Accessed July 25, 2022.
  • Toelle BG, Ampon RD, Abramson MJ, et al. Prevalence of chronic obstructive pulmonary disease with breathlessness in Australia: weighted using the 2016 Australian census. Intern Med J. 2021;51(5):784–787. doi:10.1111/imj.15325
  • Viegi G, Pistelli F, Sherrill D, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30(5):993–1013. doi:10.1183/09031936.00082507
  • Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J AU. 2013;198(3):144–148. doi:10.5694/mja11.11640
  • Dabscheck E, George J, Hermann K, et al. COPD‐X Australian guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2022 update. Med J AU. 2022;217(8):415–423. doi:10.5694/mja2.51708
  • Cooksley NA, Atkinson D, Marks GB, et al. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: the cross‐sectional BOLD study. Respirology. 2015;20(5):766–774. doi:10.1111/resp.12482
  • Janson C, Marks G, Buist S, et al. The impact of COPD on health status: findings from the BOLD study. Eur Respir J. 2013;42(6):1472–1483. doi:10.1183/09031936.00153712
  • Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease initiative (BOLD): rationale and design. J Chronic Obstr Pulm Dis. 2005;2(2):277–283. doi:10.1081/COPD-57610
  • Australian Bureau Of Statistics. Socio-economic indexes for areas (SEIFA). Australian Bureau of Statistics; 2011.
  • Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
  • Kosinski M, Ware JE, Turner-Bowker DM, Gandek B. User’s Manual for the SF-12v2 Health Survey: With a Supplement Documenting the SF-12® Health Survey. QualityMetric Incorporated; 2007.
  • Miller M. ATS/ERS task force: standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.00034805
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respiratory Soc. 2012;40:1324–1343.
  • Lederer DJ, Bell SC, Branson RD, et al. Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc. 2019;16(1):22–28. doi:10.1513/AnnalsATS.201808-564PS
  • Petrie K, Toelle BG, Wood-Baker R, et al. Undiagnosed and misdiagnosed chronic obstructive pulmonary disease: data from the BOLD Australia Study. Int J Chron Obstruct Pulmon Dis. 2021;16:467. doi:10.2147/COPD.S287172
  • Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(9):1130–1139. doi:10.1164/rccm.201804-0621CI
  • Reddel HK, Vestbo J, Agustí A, et al. Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort. Eur Respir J. 2021;58(3):2003927. doi:10.1183/13993003.03927-2020
  • Menezes AMB, de Oca MM, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304. doi:10.1378/chest.13-0622
  • Dierick BJ, Flokstra-de Blok BM, van der Molen T, et al. Work absence in patients with asthma and/or COPD: a population-based study. NPJ Prim Care Respir Med. 2021;31(1):9. doi:10.1038/s41533-021-00217-z
  • Choi HS, Yang D-W, Rhee CK, et al. The health-related quality-of-life of chronic obstructive pulmonary disease patients and disease-related indirect burdens. Korean J Intern Med. 2020;35(5):1136. doi:10.3904/kjim.2018.398
  • Varela ML, De Oca MM, Halbert R, et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J. 2010;36(5):1034–1041. doi:10.1183/09031936.00165409
  • Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
  • Gudmundsson G, Gislason T, Lindberg E, et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res. 2006;7(1):1–8. doi:10.1186/1465-9921-7-109
  • Schermer TR, Robberts B, Crockett AJ, et al. Should the diagnosis of COPD be based on a single spirometry test? NPJ Prim Care Respir Med. 2016;26(1):1–8. doi:10.1038/npjpcrm.2016.59